LY2334737
|
L646572-2mg
|
≥98% |
892128-60-8 |
2mg
|
¥ 1463.9
|
期货,请咨询 |
阿拉丁 |
LY2334737
|
L646572-10mg
|
≥98% |
892128-60-8 |
10mg
|
¥ 3348.9
|
期货,请咨询 |
阿拉丁 |
LY2334737
|
L646572-100mg
|
≥98% |
892128-60-8 |
100mg
|
¥ 12369.9
|
期货,请咨询 |
阿拉丁 |
利奈唑胺 d3
|
L646472-5mg
|
≥99%,≥98atom%D |
1127120-38-0 |
5mg
|
¥ 6999.9
|
期货,请咨询 |
阿拉丁 |
利奈唑胺 d3
|
L646472-1mg
|
≥99%,≥98atom%D |
1127120-38-0 |
1mg
|
¥ 1980.9
|
现货 |
阿拉丁 |
LIMK1 inhibitor BMS-4
|
L646464-5mg
|
≥99% |
905298-84-2 |
5mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
LY2452473
|
L646443-5mg
|
≥98% |
1029692-15-6 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
LY2452473
|
L646443-50mg
|
≥98% |
1029692-15-6 |
50mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
LY2452473
|
L646443-10mg
|
≥98% |
1029692-15-6 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
LY2452473
|
L646443-100mg
|
≥98% |
1029692-15-6 |
100mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Leriglitazone
|
L646421-5mg
|
|
146062-44-4 |
5mg
|
¥ 6200.9
|
期货,请咨询 |
阿拉丁 |
Leriglitazone
|
L646421-10mg
|
|
146062-44-4 |
10mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
Loperamide-d6hydrochloride
|
L646413-5mg
|
≥99% |
1189469-46-2 |
5mg
|
¥ 18500.9
|
期货,请咨询 |
阿拉丁 |
Loperamide-d6hydrochloride
|
L646413-1mg
|
≥99% |
1189469-46-2 |
1mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Lonapalene
|
L646394-5mg
|
≥99% |
91431-42-4 |
5mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
Lonapalene
|
L646394-1mg
|
≥99% |
91431-42-4 |
1mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
Lonapalene
|
L646394-10mg
|
≥99% |
91431-42-4 |
10mg
|
¥ 9700.9
|
期货,请咨询 |
阿拉丁 |
L-Leucine-1-13C,15N
|
L646385-5mg
|
≥98% |
80134-83-4 |
5mg
|
¥ 500.9
|
期货,请咨询 |
阿拉丁 |
L-Leucine-1-13C,15N
|
L646385-50mg
|
≥98% |
80134-83-4 |
50mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
L-Leucine-1-13C,15N
|
L646385-25mg
|
≥98% |
80134-83-4 |
25mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
L-Leucine-1-13C,15N
|
L646385-10mg
|
≥98% |
80134-83-4 |
10mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
L-Leucine-1-13C,15N
|
L646385-100mg
|
≥98% |
80134-83-4 |
100mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
L-372662
|
L646313-5mg
|
≥98% |
162045-26-3 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
L-372662
|
L646313-50mg
|
≥98% |
162045-26-3 |
50mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |